Chiropractors and acupuncturists have lobbied for a greater role in treating pain. They might well have won it. Last week, the FDA released proposed changes Wednesday to its blueprint on educating health care providers about treating pain, which now recommend that doctors learn about chiropractic care and acupuncture as therapies that might help patients avoid opioids. There’s still time to stop this, but you have to write the FDA.
This week, the FDA sent warning letters to 14 companies making unsupported claims that their products can treat cancer. Given the new administration’s determination to deregulate almost everything, but especially the FDA, is this the last time in the foreseeable future that such a crackdown will occur?
Last month, the Texas Medical Board fined Houston cancer quack Dr. Stanislaw Burzynski and placed his practice under supervision. It did not strip him of his medical license, as he deserves. The result is that families of children with terminal cancer are once again raising hundreds of thousands of dollars to follow his siren song of false hope.
Ill-advised right-to-try bills are spreading like kudzu through state legislatures. Now federal legislators want to insert right-to-try language into the bill that funds FDA drug approval. Given the support of powerful Republicans for right-to-try, is it too late to stop this juggernaut and protect patients?
In less than two weeks, the Trump administration will have passed that magical “first 100 days” marker. Let’s check in and see how Donald Trump is shaping federal biomedical policy thus far. Hint: It’s deregulation über alles.
